4.7 Review

Highlights of the 12th International Bordetella Symposium

期刊

CLINICAL INFECTIOUS DISEASES
卷 71, 期 9, 页码 2521-2526

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa651

关键词

Bordetella; whooping cough; pertussis epidemiology; pertussis vaccines; Bordetella genomics

资金

  1. Universite Libre de Bruxelles
  2. Universite de Lille
  3. National Institute of Allergy and Infectious Diseases [1 R13AI 145245-01]
  4. US Food and Drug Administration [1R13FD006613-01]
  5. ILiAD Biotechnologies
  6. GlaxoSmithKline
  7. BioNet
  8. Microbiology Society
  9. Sanofi Pasteur

向作者/读者索取更多资源

To commemorate the 100th anniversary of the Nobel prize being awarded to Jules Bordet, the discoverer of Bordetella pertussis, the 12th International Bordetella Symposium was held from 9 to 12 April 2019 at the Universite Libre de Bruxelles, where Jules Bordet studied and was Professor of Microbiology. The symposium attracted more than 300 Bordetella experts from 34 countries. They discussed the latest epidemiologic data and clinical aspects of pertussis, Bordetella biology and pathogenesis, immunology and vaccine development, and genomics and evolution. Advanced technological and methodological tools provided novel insights into the genomic diversity of Bordetella and a better understanding of pertussis disease and vaccine performance. New molecular approaches revealed previously unrecognized complexity of virulence gene regulation. Innovative insights into the immune responses to infection by Bordetella resulted in the development of new vaccine candidates. Such discoveries will aid in the design of more effective approaches to control pertussis and other Bordetella-related diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据